Corrigendum to Facile fabrication of flexible glutamate biosensor using direct writing of platinum nanoparticle-based nanocomposite ink

Nolan, James K; Park, Hyunsu; Lam, Stephanie; Fattah, Mara; Joe, Hang-Eun; Jun, Martin B. G.; Lee, Hyungwoo; Kim, Sang Joon; Shi, Riyi; Lee, Hyowon

doi:10.1016/j.bios.2019.111429

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, batch production of probes is possible with the commercial clean room fabrication process, bringing the total cost of the sensor down to an affordable range. Recently, with the advance in technology, 3D-printed electrochemical sensors have been introduced into the field to compensate for the time-intensive labor required for the existing clean room fabrication process, making the fabrication process easier and more cost-effective [ 99 ].…”

Section: Biosensor Platformsmentioning

confidence: 99%

Towards Multiplexed and Multimodal Biosensor Platforms in Real-Time Monitoring of Metabolic Disorders

Chung

Nguyen

Zhang

et al. 2022

Sensors

View full text Add to dashboard Cite

Metabolic syndrome (MS) is a cluster of conditions that increases the probability of heart disease, stroke, and diabetes, and is very common worldwide. While the exact cause of MS has yet to be understood, there is evidence indicating the relationship between MS and the dysregulation of the immune system. The resultant biomarkers that are expressed in the process are gaining relevance in the early detection of related MS. However, sensing only a single analyte has its limitations because one analyte can be involved with various conditions. Thus, for MS, which generally results from the co-existence of multiple complications, a multi-analyte sensing platform is necessary for precise diagnosis. In this review, we summarize various types of biomarkers related to MS and the non-invasively accessible biofluids that are available for sensing. Then two types of widely used sensing platform, the electrochemical and optical, are discussed in terms of multimodal biosensing, figure-of-merit (FOM), sensitivity, and specificity for early diagnosis of MS. This provides a thorough insight into the current status of the available platforms and how the electrochemical and optical modalities can complement each other for a more reliable sensing platform for MS.

show abstract

Section: Biosensor Platformsmentioning

confidence: 99%